(Q30794739)

26 June 2017

Stage-dependent gene expression profiles during natural killer cell development (English)

1 reference

26 June 2017

8

Pyung-Keun Myung

1 reference

26 June 2017

Hyung-Sik Kang

1

1 reference

26 June 2017

Eun-Mi Kim

2

1 reference

26 June 2017

Sanggyu Lee

3

1 reference

26 June 2017

Suk-Ran Yoon

4

1 reference

26 June 2017

Toshihiko Kawamura

5

1 reference

26 June 2017

Young-Cheol Lee

6

1 reference

26 June 2017

Sangsoo Kim

7

1 reference

26 June 2017

San Ming Wang

9

1 reference

26 June 2017

Inpyo Choi

10

1 reference

26 June 2017

28 July 2005

1 reference

26 June 2017

1 reference

26 June 2017

86

1 reference

26 June 2017

5

1 reference

26 June 2017

551-565

1 reference

What is a natural killer cell?

26 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.06.010

Natural killer cell activation in mice and men: different triggers for similar weapons?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.06.010

Induction of tumor-specific T cell memory by NK cell–mediated tumor rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.06.010

Natural killer cells determine the outcome of B cell–mediated autoimmunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.06.010

Natural killer cells determine development of allergen-induced eosinophilic airway inflammation in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.06.010

Role of natural killer cells in the development of graft-versus-host disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.06.010

Natural killer and lymphokine activated killer cell functions in Hodgkin's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.06.010

Natural killer cells and the pathogenesis of systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.06.010

Development and tolerance of natural killer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.06.010

Lymphocyte development from hematopoietic stem cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.06.010

Murine natural killer cell progenitors and their requirements for development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.06.010

What does it take to make a natural killer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.06.010

Lack of natural killer cell precursors in fetal liver of Ikaros knockout mutant mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.06.010

Differential requirement for the transcription factor PU.1 in the generation of natural killer cells versus B and T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.06.010

Commitment to natural killer cells requires the helix-loop-helix inhibitor Id2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.06.010

Ligands for natural killer cell receptors: redundancy or specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.06.010

On guard--activating NK cell receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.06.010

Orderly and nonstochastic acquisition of CD94/NKG2 receptors by developing NK cells derived from embryonic stem cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.06.010

Expression of Ly49E and CD94/NKG2 on fetal and adult NK cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.06.010

Clonal acquisition of inhibitory Ly49 receptors on developing NK cells is successively restricted and regulated by stromal class I MHC.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.06.010

Signal via lymphotoxin-beta R on bone marrow stromal cells is required for an early checkpoint of NK cell development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.06.010

Requirement for IRF-1 in the microenvironment supporting development of natural killer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.06.010

Requirement for membrane lymphotoxin in natural killer cell development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.06.010

Clonal analysis of NK cell development from bone marrow progenitors in vitro: orderly acquisition of receptor gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.06.010

Defective interleukin (IL)-18-mediated natural killer and T helper cell type 1 responses in IL-1 receptor-associated kinase (IRAK)-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.06.010

Natural Killer (NK) cell deficiency associated with an epitope-deficient Fc receptor type IIIA (CD16-II)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.06.010

A role for the src family kinase Fyn in NK cell activation and the formation of the repertoire of Ly49 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.06.010

RETRACTED: Silencing of B cell receptor signals in human naive B cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.06.010

Gene expression profile in human leukocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.06.010

The pattern of gene expression in human CD15+ myeloid progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.06.010

Biological insights into TCRgammadelta+ and TCRalphabeta+ intraepithelial lymphocytes provided by serial analysis of gene expression (SAGE).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.06.010

In vivo developmental stages in murine natural killer cell maturation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.06.010

Fibroblasts from human spleen regulate NK cell differentiation from blood CD34(+) progenitors via cell surface IL-15

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.06.010

The Ets-1 transcription factor is required for the development of natural killer cells in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.06.010

The ETS protein MEF plays a critical role in perforin gene expression and the development of natural killer and NK-T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.06.010

Inhibition of murine erythroleukemia cell differentiation by normal and partially deleted c-myc genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.06.010

Lipoprotein lipase and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.06.010

Lipoprotein lipase: structure, function, regulation, and role in disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.06.010

Prostaglandin E2 Suppresses NK Activity In Vivo and Promotes Postoperative Tumor Metastasis in Rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.06.010

Comparison of the effect of lipoxygenase metabolites of arachidonic acid and eicosapentaenoic acid on human natural killer cell cytotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.06.010

Novel insights on human NK cells' immunological modalities revealed by gene expression profiling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.06.010

DNA microarray analysis of natural killer cell-type lymphoproliferative disease of granular lymphocytes with purified CD3-CD56+ fractions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.06.010

Generation of lytic natural killer 1.1+, Ly-49- cells from multipotential murine bone marrow progenitors in a stroma-free culture: definition of cytokine requirements and developmental intermediates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.06.010

Analysis of human transcriptomes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2005.06.010

10.1016/J.YGENO.2005.06.010

7 January 2021

Identifiers

DOI

1 reference

26 June 2017

1 reference